-
1
-
-
0029095150
-
Polycystic ovary syndrome
-
Franks S. Polycystic ovary syndrome. New Engl J Med. 1995 ; 333 (13). 853-861.
-
(1995)
New Engl J Med.
, vol.333
, Issue.13
, pp. 853-861
-
-
Franks, S.1
-
2
-
-
0025634135
-
Long term treatment with the combination ethinyl-estradiol and cyproterone acetate in polycystic ovary syndrome
-
Falsetti L., Galbignani E. Long term treatment with the combination ethinyl-estradiol and cyproterone acetate in polycystic ovary syndrome. Contraception. 1990 ; 42 (6). 611-619.
-
(1990)
Contraception
, vol.42
, Issue.6
, pp. 611-619
-
-
Falsetti, L.1
Galbignani, E.2
-
3
-
-
42149163918
-
Conway. A systemic review of commonly used medical treatments for hirsutism in women
-
Olympia K., Gerard S. Conway. A systemic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol. 2008 ; 68 (5). 800-805.
-
(2008)
Clin Endocrinol
, vol.68
, Issue.5
, pp. 800-805
-
-
Olympia, K.1
Gerard, S.2
-
4
-
-
33750996161
-
Update on the management of polycystic ovary syndrome
-
Krysiak R., Okopieà± B., Gdula-Dymek A., Herman ZS Update on the management of polycystic ovary syndrome. Pharmacol Rep. 2006 ; 58 (5). 614-625.
-
(2006)
Pharmacol Rep.
, vol.58
, Issue.5
, pp. 614-625
-
-
Krysiak, R.1
Okopieà, B.2
Gdula-Dymek, A.3
Herman, Z.S.4
-
6
-
-
0029152127
-
Sex hormone-binding globulin and female reproductive function
-
Botwood N., Hamilton-Fairley D., Kiddy D., Robinson S., Franks S. Sex hormone-binding globulin and female reproductive function. J Steroid Biochem Mol Biol. 1995 ; 53 (1-6). 529-531.
-
(1995)
J Steroid Biochem Mol Biol.
, vol.53
, Issue.1-6
, pp. 529-531
-
-
Botwood, N.1
Hamilton-Fairley, D.2
Kiddy, D.3
Robinson, S.4
Franks, S.5
-
7
-
-
0026783565
-
Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation
-
Toscano V., Balducci R., Bianchi P., Guglielmi R., Mangiantini A., Sciarra F. Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem Mol Biol. 1992 ; 43 (5). 431-437.
-
(1992)
J Steroid Biochem Mol Biol
, vol.43
, Issue.5
, pp. 431-437
-
-
Toscano, V.1
Balducci, R.2
Bianchi, P.3
Guglielmi, R.4
Mangiantini, A.5
Sciarra, F.6
-
8
-
-
19244367470
-
Acute myocardial infarction and combined oral contraceptives: Results of international multicenter case-control study
-
WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception
-
WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of international multicenter case-control study. Lancet. 1997 ; 349 (9060). 1202-1209.
-
(1997)
Lancet
, vol.349
, Issue.9060
, pp. 1202-1209
-
-
-
9
-
-
0035984973
-
Long-term health consequences of PCOS
-
Wild RA Long-term health consequences of PCOS. Hum Reprod Update. 2002 ; 8 (3). 231-241.
-
(2002)
Hum Reprod Update
, vol.8
, Issue.3
, pp. 231-241
-
-
Wild, R.A.1
-
10
-
-
0034838348
-
Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon)
-
Worret I., Arp W., Zahradnik HP, Zahradnik HP, Andreas JO, Binder N. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology. 2001 ; 203 (1). 38-44.
-
(2001)
Dermatology
, vol.203
, Issue.1
, pp. 38-44
-
-
Worret, I.1
Arp, W.2
Zahradnik, H.P.3
Zahradnik, H.P.4
Andreas, J.O.5
Binder, N.6
-
11
-
-
0037383049
-
A 12-month evaluation of the CMAcontaining oral contraceptive Belara: Efficacy, tolerability and anti-androgenic properties
-
Schramm G., Steffens D. A 12-month evaluation of the CMAcontaining oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties. Contraception. 2003 ; 67 (4). 305-312.
-
(2003)
Contraception
, vol.67
, Issue.4
, pp. 305-312
-
-
Schramm, G.1
Steffens, D.2
-
12
-
-
71149100877
-
Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: Physical and emotional benefits
-
Heskamp ML, Schramm GA Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits. Contraception. 2010 ; 81 (1). 49-56.
-
(2010)
Contraception.
, vol.81
, Issue.1
, pp. 49-56
-
-
Heskamp, M.L.1
Schramm, G.A.2
-
13
-
-
61449101283
-
Profile of the progesterone derivative chlormadinone acetate- pharmocodynamic properties and therapeutic applications
-
Druckmann R. Profile of the progesterone derivative chlormadinone acetate-pharmocodynamic properties and therapeutic applications. Contraception. 2009 ; 79 (4). 272-281.
-
(2009)
Contraception
, vol.79
, Issue.4
, pp. 272-281
-
-
Druckmann, R.1
-
14
-
-
29044448524
-
Chlormadinone acetate (CMA) in oral contraception-a new opportunity
-
Bouchard P. Chlormadinone acetate (CMA) in oral contraception-a new opportunity. Eur J Contracept Reprod Health Care. 2005 ; 10 (suppl 1). 7-11.
-
(2005)
Eur J Contracept Reprod Health Care
, vol.10
, Issue.1
, pp. 7-11
-
-
Bouchard, P.1
-
15
-
-
67349136077
-
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: A randomized, double-blind, placebo-controlled Phase III trial
-
Plewig G., Cunliffe WJ, Binder N., Höschen K. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. Contraception. 2009 ; 80 (1). 25-33.
-
(2009)
Contraception.
, vol.80
, Issue.1
, pp. 25-33
-
-
Plewig, G.1
Cunliffe, W.J.2
Binder, N.3
Höschen, K.4
-
16
-
-
0036075587
-
Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment
-
Carranza-Lira S., Magaà±a-Padilla NR Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment. Ginecol Obstet Mex. 2002 ; 70 (6). 285-288.
-
(2002)
Ginecol Obstet Mex.
, vol.70
, Issue.6
, pp. 285-288
-
-
Carranza-Lira, S.1
Magaàa-Padilla, N.R.2
-
17
-
-
0343832020
-
The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome
-
Carranza-Lira S., Garcàa-Hernández E., Baiza MR, Morán C. The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 1996 ; 66 (2). 161-164.
-
(1996)
Eur J Obstet Gynecol Reprod Biol
, vol.66
, Issue.2
, pp. 161-164
-
-
Carranza-Lira, S.1
Garcàa-Hernández, E.2
Baiza, M.R.3
Morán, C.4
-
19
-
-
0346186090
-
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
-
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 ; 19 (1). 41-47.
-
(2004)
Hum Reprod
, vol.19
, Issue.1
, pp. 41-47
-
-
-
20
-
-
0034901923
-
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: The ovarian stroma/total area ratio
-
Fulghesu AM, Ciampelli M., Belosi C., et al. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril. 2001 ; 76 (2). 326-331.
-
(2001)
Fertil Steril
, vol.76
, Issue.2
, pp. 326-331
-
-
Fulghesu, A.M.1
Ciampelli, M.2
Belosi, C.3
-
21
-
-
0032833231
-
Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 years old adolescents
-
Van Hooff MH, Voorhorst FJ, et al. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 years old adolescents. Hum Reprod. 1999 ; 14 (9). 2223-2229.
-
(1999)
Hum Reprod
, vol.14
, Issue.9
, pp. 2223-2229
-
-
Van Hooff, M.H.1
Voorhorst, F.J.2
-
22
-
-
0020556434
-
Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
-
New MI, Lorenzen F., Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983 ; 57 (2). 320-326.
-
(1983)
J Clin Endocrinol Metab
, vol.57
, Issue.2
, pp. 320-326
-
-
New, M.I.1
Lorenzen, F.2
Lerner, A.J.3
-
23
-
-
12644305063
-
Clinical assessment of body hair growth in women
-
Ferriman D., Gallwey JD Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961 ; 21: 1440-1447.
-
(1961)
J Clin Endocrinol Metab
, vol.21
, pp. 1440-1447
-
-
Ferriman, D.1
Gallwey, J.D.2
-
24
-
-
0019721421
-
Decreased insulin removal contributes to hyperinsulinemic in obesity
-
Faber OK, Christensen K., Kehelet H., Madsbad S., Binder C. Decreased insulin removal contributes to hyperinsulinemic in obesity. J Clin Endocrinol Metab. 1981 ; 53 (3). 618-621.
-
(1981)
J Clin Endocrinol Metab
, vol.53
, Issue.3
, pp. 618-621
-
-
Faber, O.K.1
Christensen, K.2
Kehelet, H.3
Madsbad, S.4
Binder, C.5
-
25
-
-
0018520840
-
Glucose clamp technique: A method for quantifying insulin secretion and resistance
-
De Fronzo JP, Tobin JD, Andrei R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 ; 237 (3). E214 - E223.
-
(1979)
Am J Physiol.
, vol.237
, Issue.3
-
-
De Fronzo, J.P.1
Tobin, J.D.2
Andrei, R.3
-
26
-
-
0022361971
-
Assessment of insulin sensitivity in vivo
-
Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985 ; 6 (1). 45-86.
-
(1985)
Endocr Rev
, vol.6
, Issue.1
, pp. 45-86
-
-
Bergman, R.N.1
Finegood, D.T.2
Ader, M.3
-
27
-
-
0033007007
-
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome
-
Ciampelli M., Fulghesu AM, Cucinelli F., et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999 ; 48 (2). 167-172.
-
(1999)
Metabolism
, vol.48
, Issue.2
, pp. 167-172
-
-
Ciampelli, M.1
Fulghesu, A.M.2
Cucinelli, F.3
-
28
-
-
0032739105
-
The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices
-
Rivera R., Yacobson I., Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999 ; 181 (5 Pt 1). 1263-1269.
-
(1999)
Am J Obstet Gynecol.
, vol.181
, Issue.5 PART 1
, pp. 1263-1269
-
-
Rivera, R.1
Yacobson, I.2
Grimes, D.3
-
29
-
-
0032034169
-
Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism
-
Crook D., Godsland I. Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception. 1998 ; 57 (3). 189-201.
-
(1998)
Contraception
, vol.57
, Issue.3
, pp. 189-201
-
-
Crook, D.1
Godsland, I.2
-
30
-
-
0019215829
-
Insulin receptors on monocytes and erythrocytes from obese patients
-
De Pirro R., Fusco A., Lauro R., et al. Insulin receptors on monocytes and erythrocytes from obese patients. J Clin Endocrinol Metab. 1980 ; 51 (6). 1437-1439.
-
(1980)
J Clin Endocrinol Metab
, vol.51
, Issue.6
, pp. 1437-1439
-
-
De Pirro, R.1
Fusco, A.2
Lauro, R.3
-
31
-
-
0026579457
-
Insulin resistance, secretion, and metabolism in users of oral contraceptives
-
Godsland IF, Walton C., Felton C., et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 1992 ; 74 (1). 64-70.
-
(1992)
J Clin Endocrinol Metab
, vol.74
, Issue.1
, pp. 64-70
-
-
Godsland, I.F.1
Walton, C.2
Felton, C.3
-
32
-
-
13544263383
-
A 1-yr randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 1/4g ethinyl estradiol combined with 100 1/4g levonorgesterel
-
Skouby SO, Endrikat J., Dusterberg B., et al. A 1-yr randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 1/4g ethinyl estradiol combined with 100 1/4g levonorgesterel. Contraception. 2005 ; 71 (2). 111-117.
-
(2005)
Contraception
, vol.71
, Issue.2
, pp. 111-117
-
-
Skouby, S.O.1
Endrikat, J.2
Dusterberg, B.3
-
33
-
-
42449157428
-
Steroidal contraceptives: Effect on carbohydrate metabolism in women without diabetes mellitus
-
Lopez LM, Grimes DA, Schulz KF Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev. 2007 ;(2). CD006133.
-
(2007)
Cochrane Database Syst Rev.
, Issue.2
, pp. 006133
-
-
Lopez, L.M.1
Grimes, D.A.2
Schulz, K.F.3
-
34
-
-
0242286063
-
Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism
-
Làdicke F., Gaspard UJ, Demeyer F., Scheen A., Lefebvre P. Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception. 2002 ; 66 (6). 411-415.
-
(2002)
Contraception
, vol.66
, Issue.6
, pp. 411-415
-
-
Làdicke, F.1
Gaspard, U.J.2
Demeyer, F.3
Scheen, A.4
Lefebvre, P.5
-
35
-
-
84995865301
-
Induction of insulin resistance by estrogens and androgens
-
Polderman KH, Gooren LJG, Asscheman H., et al. Induction of insulin resistance by estrogens and androgens. J Clin Endocrinol Metab. 1994 ; 79 (1). 265-271.
-
(1994)
J Clin Endocrinol Metab
, vol.79
, Issue.1
, pp. 265-271
-
-
Polderman, K.H.1
Ljg, G.2
Asscheman, H.3
-
36
-
-
77952787136
-
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
-
Wild RA, Carmina E., Diamanti-Kandarakis E., Dokras A., et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 May; 95 (5). 2038-2049.
-
(2010)
J Clin Endocrinol Metab.
, vol.95
, Issue.5
, pp. 2038-2049
-
-
Wild, R.A.1
Carmina, E.2
Diamanti-Kandarakis, E.3
Dokras, A.4
-
37
-
-
58149147337
-
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: A randomized trial
-
Cagnacci A., Ferrari S., Tirelli A., et al. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial. Contraception. 2009 ; 79 (2). 111-116.
-
(2009)
Contraception.
, vol.79
, Issue.2
, pp. 111-116
-
-
Cagnacci, A.1
Ferrari, S.2
Tirelli, A.3
-
38
-
-
56549093574
-
The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters
-
Winkler UH, Sudik R. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters. Contraception. 2009 ; 79 (2). 15-23.
-
(2009)
Contraception.
, vol.79
, Issue.2
, pp. 15-23
-
-
Winkler, U.H.1
Sudik, R.2
-
39
-
-
17044444359
-
Comparative evaluation of the androgenecity of four low-dose, fixed combination oral contraceptives
-
Coenen C., Thomas C., Borm G., et al. Comparative evaluation of the androgenecity of four low-dose, fixed combination oral contraceptives. Int J Fertil. 1995 ; 40 (suppl 2). 92-97.
-
(1995)
Int J Fertil
, vol.40
, Issue.2
, pp. 92-97
-
-
Coenen, C.1
Thomas, C.2
Borm, G.3
-
40
-
-
18444372363
-
Uddin M. Effects of low dose oral contraceptives on serum total cholesterol, TAG, HDL-C & LDL-C levels in contraceptive users
-
Nessa A., Latif SA, Uddin M. Effects of low dose oral contraceptives on serum total cholesterol, TAG, HDL-C & LDL-C levels in contraceptive users. Mymensingh Med J. 2005 ; 14 (1). 26-28.
-
(2005)
Mymensingh Med J
, vol.14
, Issue.1
, pp. 26-28
-
-
Nessa, A.1
Latif, S.A.2
-
41
-
-
0038531042
-
Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel
-
Kiran G., Kiran H., Ekerbicer HC, Aust NZ Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel. J Obstet Gynaecol. 2003 ; 43 (2). 145-147.
-
(2003)
J Obstet Gynaecol
, vol.43
, Issue.2
, pp. 145-147
-
-
Kiran, G.1
Kiran, H.2
Ekerbicer, H.C.3
Aust, N.Z.4
-
42
-
-
0032415718
-
The new pathophysiology of coronary artery disease
-
Castelli WP The new pathophysiology of coronary artery disease. Am J Cardiol. 1998 ; 82 (10B). 60t - 65t.
-
(1998)
Am J Cardiol.
, vol.82
, Issue.10 B
-
-
Castelli, W.P.1
-
43
-
-
0035059042
-
Cardiovascular risk factors and prevention in women: Similarities and differences
-
Sclavo M. Cardiovascular risk factors and prevention in women: similarities and differences. Ital Heart J. 2001 ; 2 (suppl 2). 125-141.
-
(2001)
Ital Heart J
, vol.2
, Issue.2
, pp. 125-141
-
-
Sclavo, M.1
-
44
-
-
0029766983
-
Regulation of VLDL synthesis and secretion in the liver
-
Gruffat D., Durand D., Graulet B., Bauchart D. Regulation of VLDL synthesis and secretion in the liver. Reprod Nutr Dev. 1996 ; 36 (4). 375-389. Review.
-
(1996)
Reprod Nutr Dev.
, vol.36
, Issue.4
, pp. 375-389
-
-
Gruffat, D.1
Durand, D.2
Graulet, B.3
Bauchart, D.4
-
45
-
-
0020641610
-
Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol
-
Wahl R., Walden C., Knopp R., et al. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med. 1993 ; 308 (15). 862-867.
-
(1993)
N Engl J Med.
, vol.308
, Issue.15
, pp. 862-867
-
-
Wahl, R.1
Walden, C.2
Knopp, R.3
-
46
-
-
0027287971
-
Effects of low dose oral contraceptive on very low density lipoprotein metabolism
-
Walsh BW, Sacks FM Effects of low dose oral contraceptive on very low density lipoprotein metabolism. J. Clin Invest. 1993 ; 91 (5). 2126-2132.
-
(1993)
J. Clin Invest
, vol.91
, Issue.5
, pp. 2126-2132
-
-
Walsh, B.W.1
Sacks, F.M.2
-
47
-
-
35348965152
-
Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents
-
Sabatini R., Orsini G., Cagiano R., et al. Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents. Contraception. 2007 ; 76 (5). 342-347.
-
(2007)
Contraception
, vol.76
, Issue.5
, pp. 342-347
-
-
Sabatini, R.1
Orsini, G.2
Cagiano, R.3
-
48
-
-
0037228146
-
Progestogens with antiandrogenic properties
-
Raudrant D., Rabe T. Progestogens with antiandrogenic properties. Drug. 2003 ; 63 (5). 463-492.
-
(2003)
Drug
, vol.63
, Issue.5
, pp. 463-492
-
-
Raudrant, D.1
Rabe, T.2
-
49
-
-
0037203511
-
Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line
-
Tà©rouanne B., Paris F., Servant N., Georget V., Sultan C. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line. Mol Cell Endocrinol. 2002 ; 198 (1-2). 143-147.
-
(2002)
Mol Cell Endocrinol
, vol.198
, Issue.1-2
, pp. 143-147
-
-
Tàrouanne, B.1
Paris, F.2
Servant, N.3
Georget, V.4
Sultan, C.5
-
50
-
-
0030693350
-
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
-
Lucky AW, Henderson TA, Olson WH, et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997 ; 37 (5 pt 1). 746-754.
-
(1997)
J Am Acad Dermatol.
, vol.37
, Issue.5 PART 1
, pp. 746-754
-
-
Lucky, A.W.1
Henderson, T.A.2
Olson, W.H.3
-
51
-
-
0029103321
-
Chlormadinone acetate as a possible effecrive agent for congenital adrenal hyperplasia to suppress elevated ACTH and antagonize masculinization
-
Kageyama Y., Kitahara S., Tsukamoto T., Tsujii T., Goto S., Oshima H. Chlormadinone acetate as a possible effecrive agent for congenital adrenal hyperplasia to suppress elevated ACTH and antagonize masculinization. Endocr J. 1995 ; 42 (4). 505-508.
-
(1995)
Endocr J
, vol.42
, Issue.4
, pp. 505-508
-
-
Kageyama, Y.1
Kitahara, S.2
Tsukamoto, T.3
Tsujii, T.4
Goto, S.5
Oshima, H.6
-
52
-
-
0034874411
-
The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia
-
Murakoshi M., Ikeda R., Fukui N. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia. J Toxicol Sci. 2001 ; 26 (3). 119-127.
-
(2001)
J Toxicol Sci
, vol.26
, Issue.3
, pp. 119-127
-
-
Murakoshi, M.1
Ikeda, R.2
Fukui, N.3
|